Pharma Stories & Articles

Download PDF

Register to download the report. Already a member?

Sign Up


63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Pharma Stories & Articles


Tunisia: Diabetes on the Rise


Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes is the second largest cause of death in Tunisia”. Moez …

India: Creating An Innovative Healthcare Ecosystem


At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based pharmaceutical companies in India, putting the patient at the center of all that they do is part of their DNA. On the occasion of their 51st …

Colombia: Ramping up the Local Footprint


With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for multinationals, not only to set up shop in the sense of establishing a direct local affiliate, but also …

Tunisia: A New Framework for Biotech Investments


The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th 2017 at the Tunis export centre (CEPEX) and revolved around …

Austria: Nucleus of Clinical Trials


Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia, willing volunteers and educated medical personnel balanced against a backdrop …

Austria: Orchestrating Innovation


Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research giants, Germany and Switzerland. Now, however, this perception is changing as Austria capitalizes on its ideal central European location and …

Euratom: Where Are We Now?


Hamid Yunis, partner and head of healthcare at the London office of international law firm, McDermott Will & Emery, discusses the potential negative impact of Brexit and the UK leaving the European Atomic Energy Community (Euratom) on cancer care in …

Hong Kong: A Clinical Trials Destination


Small markets must inevitably etch out a niche positioning for themselves, and for Hong Kong, its world-class medical infrastructure, world-renowned academics and clinicians as well as high population density make it a strong contender in clinical research. “Hong Kong is …

Hong Kong: Land of the Biotech Unicorns


In 2017, Hong Kong fended off perennial competitors, life sciences hubs and innovation powerhouses, Switzerland and Singapore, to rank first in the International Institute for Management Development (IMD)’s World Competitiveness Rankings, clear evidence that conditions are ripe in Hong Kong …

The Indonesian Halal Law: A Headache for Pharma


The Halal Product Assurance Law, enacted in 2014 and due to be implemented across Indonesia in 2019, will mandate that all food and drink that that enters, is distributed, and is traded in Indonesia must be halal certified. However, the …

Countering NCDs in Algeria


Long considered maladies of affluent urban populations in mature Western economies, non communicable diseases (NCDs)– such as diabetes, cancer, chronic respiratory and cardiovascular diseases – have been spreading silently and unchecked throughout the African continent to the point where they …

Expanscience Mexico along with its key brand Mustela reveals the physiology of babies’ skin via a 10 year research called E.V.E.I.L.S.


More about Laboratoire Expanscience Mexico : More about Mustela Mexico :



Most Read

Download PDF

First Name:

Last Name: